Home
About
Our Team
Contact
Disclaimer
Search
Newsy Trends
NASDAQ / OTC / PINK SHEETS
Newsy Trends
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
About
Our Team
Contact
Disclaimer
Sign in / Join
10.8
C
Munich
Newsy Trends
NASDAQ / OTC / PINK SHEETS
Friday, March 24, 2023
type here...
Search
Emerging Markets
Energy & Resources
Featured
Media & Technology
BioPharma
Stocks
Newsy Trends
Emerging Markets
Energy & Resources
Featured
Media & Technology
BioPharma
Stocks
- Advertisement -
AUTHOR NAME
Van Leopold
6 POSTS
0 COMMENTS
Emerging Markets
Houston Natural Resources, Inc. (OTCMKTS: HNRC) Heats Up as Oil & Gas Operator Reports Record Fiscal 2022 Financial Results and SPAC HNR Acquisition Corp...
Van Leopold
-
March 7, 2023
Houston Natural Resources, Inc. (OTCMKTS: HNRC) is making a big move up the charts since reversing off 52-week lows of $0.062. HNRC is a...
Emerging Markets
China Dongsheng International, Inc. (OTCMKTS: CDSG) Heats Up as Co Reports Positive Soil Geochemical Results at its Titan 1 & Titan 2 Lithium Properties...
Van Leopold
-
March 6, 2023
China Dongsheng International, Inc. (OTCMKTS: CDSG) is making a big move up the charts in recent days starting off around $0.03 on Wednesday of...
BioPharma
Humbl Inc (OTCMKTS: HMBL) Right Under a Penny HMBL Cancels RS and Launches HUMBL Digital Wallet offering Digital Assets, a Search Engine and Social...
Van Leopold
-
March 6, 2023
Humbl Inc (OTCMKTS: HMBL) is a sleeper trading just over 52-week lows of $0.0067 and the stock still trades well over $100,000 in dollar...
BioPharma
Akebia Therapeutics Inc (NASDAQ: AKBA) Heating Up as Auryxia Sales Accelerate & FDA Office of New Drugs (OND) Conducts Final Review on Vadadustat for...
Van Leopold
-
March 6, 2023
Akebia Therapeutics Inc (NASDAQ: AKBA) is an exciting low priced Nasdaq biotech advancing Vadadustat; an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor currently in...
BioPharma
Vivos Inc (OTCMKTS: RDGL) Heating Up as Biotech Files More Patents & Prepares for Upcoming IDE Submittal
Van Leopold
-
March 6, 2023
Vivos Inc (OTCMKTS: RDGL) continues to move steadily northbound taking out the highs of early February and moving back over $0.07 with steady buying...
BioPharma
Exela Technologies Inc (NASDAQ: XELA) Reverses off 52 Week Lows as Earnings Reports Looms & Investors wait on European Merger News, NASDAQ Update and...
Van Leopold
-
March 5, 2023
Exela Technologies Inc (NASDAQ: XELA) has been on the move in recent days moving up over its $0.05 base and 52-week lows of $0.04...
Latest news
Indo Global Exchanges Pte Ltd (OTCMKTS: IGEX) (the Mineral Company) in Focus as Investors Wait on Merger News, Pink Current and a New CEO
March 23, 2023
Vortex Brands Co (OTCMKTS: VTXB) Crypto Miner on the Move as Co Announces Cash Dividend from its Bitcoin Mining Operations
March 23, 2023
Digital Locations Inc (OTCMKTS: DLOC) In Focus as 5G Wireless Network Pioneer Gains Rights to 10,000 Pre-Qualified Wireless Cell Sites
March 23, 2023
Nano Mobile Healthcare Inc (OTCMKTS: VNTH) Heats Up as Ambitious New CEO Completes Annual Report and Repositions Company into Electric Vehicle Charging Stations
March 23, 2023
Bioadaptives Inc (OTCMKTS: BDPT) in Focus as Co Signs LOI to Create Fit Your Outfit (FYO) App Utilizing AI to Scientifically Measures Body Composition
March 23, 2023
- Advertisement -